Loading...

Real World Data on the Utilization Pattern and Safety Profile of Infliximab Originator Versus Biosimilars in Italy: A Multiregional Study

BACKGROUND: In recent years, several biosimilar drugs, including those of infliximab, have obtained marketing authorization from the European Medicines Agency (EMA). Given the peculiarity of the safety profile of biological medical products (originator and biosimilars), the evaluation of their toler...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:BioDrugs
Main Authors: Scavone, Cristina, Sessa, Maurizio, Clementi, Emilio, Corrao, Giovanni, Leone, Roberto, Mugelli, Alessandro, Rossi, Francesco, Spina, Edoardo, Capuano, Annalisa
Format: Artigo
Sprog:Inglês
Udgivet: Springer International Publishing 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6290713/
https://ncbi.nlm.nih.gov/pubmed/30341487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-018-0313-2
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!